523144 MEDICAPQ

MediCaps Share Price

 

 

MediCaps live price: ₹28. It opened at ₹26 vs previous close ₹25; intraday high/low: ₹29/₹25. The 50 & 200 DMA stand at ₹25.50/₹32.98.

MediCaps Performance

  • Today's Low
  • ₹25
  • Today's High
  • ₹29
  • 52 Week Low
  • ₹21
  • 52 Week High
  • ₹47
  • Open Price₹26
  • Previous Close₹25
  • Volume10,302
  • 50 DMA₹25.50
  • 100 DMA₹28.38
  • 200 DMA₹32.98

Investment Returns

  • Over 1 Month + 22.86%
  • Over 3 Month -11.7%
  • Over 6 Month -26.12%
  • Over 1 Year -35.6%

Smart Investing Starts Here Start SIP with MediCaps for Steady Growth!

Invest Now

MediCaps Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -8
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 35
  • P/B Ratio
  • 0.3
  • Average True Range
  • 2.43
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.16
  • RSI
  • 64.69
  • MFI
  • 75.7

MediCaps Financials

MediCaps Technicals

EMA & SMA

Current Price
₹28.00
+ 3.18 (12.81%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹24.51
  • 50 Day
  • ₹25.50
  • 100 Day
  • ₹28.38
  • 200 Day
  • ₹32.98

Resistance and Support

27.27 Pivot Speed
  • R3 32.75
  • R2 30.86
  • R1 29.16
  • S1 25.57
  • S2 23.68
  • S3 21.98

MediCaps Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-11 Quarterly Results
2025-11-12 Quarterly Results
2025-08-05 Quarterly Results
2025-05-21 Audited Results
2025-02-12 Quarterly Results

MediCaps F&O

MediCaps Shareholding Pattern

51.36%
0%
0.02%
43.92%
4.7%

MediCaps FAQs

MediCaps share price is ₹28 As on 09 April, 2026 | 03:07

The Market Cap of MediCaps is ₹34.9 Cr As on 09 April, 2026 | 03:07

The P/E ratio of MediCaps is -8 As on 09 April, 2026 | 03:07

The PB ratio of MediCaps is 0.3 As on 09 April, 2026 | 03:07

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23